Read more about Regulatory nod given to conduct clinical trials of Colchicine: CSIR on Business Standard. The Drugs Controller General of India (DCGI) has given approval to the CSIR and Laxai Life Sciences Private Limited to conduct clinical trial of Colchicine on COVID-19 patients, according to a statement on Saturday.Ram Vishwakarma, the advisor to
The Drugs Controller General of India (DCGI) has given approval to the CSIR and Laxai Life Sciences Private Limited to conduct a clinical trial of Colchicine on COVID-19 patients.
Ram Vishwakarma, the advisor to the CSIR Director-General, said Colchicine, in combination with standard care, will be an important therapeutic intervention for COVID-19 patients with cardiac co-morbidities
Read more about Barometers trade with small gains; Nifty holds 15,750 mark on Business Standard. The benchmark indices were trading with small gains in afternoon trade. At 13:20 IST, the barometer index, the S&P BSE Sensex, rose 140.04 points or 0.27% at 52,440.51. The Nifty 50 index gained 26.70 points or 0.17% at 15,764.45.